Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Jaya Swarasa Agung Tbk. (TAYS)

Brigit Biofarmaka Teknologi Tbk.Trading
Jaya Swarasa Agung Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Jaya Swarasa Agung Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Jaya Swarasa Agung Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 54,95 M). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Jaya Swarasa Agung Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

OBATTAYS
Kapitalisasi Pasar
166,01 M54,95 M
Volume
324 rb
Lot
3,24 rb
Perputaran
77,68 jt
Harga Rata-rata
239,75
Nilai Transaksi
77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OBAT
Lihat detail
TAYS
Lihat detail

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT

Tentang Jaya Swarasa Agung Tbk.

PT Jaya Swarasa Agung Tbk (the Company) was established based on Notarial Deed No. 4 dated May 1, 1998 of Trinawati Mulia, S.H., in Jakarta and has received approval as a legal entity from the Minister of Justice and Human Rights of the Republic from Indonesia dated July 19, 1999 through its Decision Letter No.C-13163.01.01.TH.99. The Company started its commercial operation in 1998.

Selengkapnya di halaman TAYS